Yahoo
    Paris - Delayed Quote EUR

    Median Technologies SA (ALMDT.PA)

    3.7300 +0.2000 (+5.67%)
    At close: 5:35:00 PM GMT+1
    Loading Chart for ALMDT.PA
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    Median Technologies Reports H1 2026 Financial Results and Q3 Business Highlights

    Median Technologies Reports H1 2026 Financial Results and Q3 Business Highlights
    Business Wire 5d ago
    Median Technologies to Showcase iCRO’s Central and AI-Powered Imaging Services for Oncology Clinical Trials at ESMO 2026

    Median Technologies to Showcase iCRO’s Central and AI-Powered Imaging Services for Oncology Clinical Trials at ESMO 2026
    Business Wire 13d ago
    Median Technologies Strengthens Its Engagement with the International Lung Cancer Screening Community at the 50th I-ELCAP Conference in New York

    Median Technologies Strengthens Its Engagement with the International Lung Cancer Screening Community at the 50th I-ELCAP Conference in New York
    Business Wire 14d ago
    eyonis Inc., a Median Technologies Company, to Present Study Results Supporting eyonis® LCS Performance Claims at CHEST 2026

    eyonis Inc., a Median Technologies Company, to Present Study Results Supporting eyonis® LCS Performance Claims at CHEST 2026
    Business Wire 20d ago
    Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of September 30, 2026

    Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of September 30, 2026
    Business Wire 22d ago
    Median Technologies: H2 2026 Financial Communication Calendar

    Median Technologies: H2 2026 Financial Communication Calendar
    Business Wire 1mo ago
    Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of August 31, 2026

    Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of August 31, 2026
    Business Wire 1mo ago
    Median Technologies Announces Formation of Strategic Review Committee and R&D Committee to Unlock Intrinsic Value and Accelerate Its eyonis® Pan-Cancer Strategy

    Median Technologies Announces Formation of Strategic Review Committee and R&D Committee to Unlock Intrinsic Value and Accelerate Its eyonis® Pan-Cancer Strategy
    Business Wire 2mo ago
    Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of July 31, 2026

    Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of July 31, 2026
    Business Wire 2mo ago
    Canon Medical Systems’ Olea Medical to Expand U.S. Access to eyonis® LCS for AI-Powered Lung Cancer Screening

    Canon Medical Systems’ Olea Medical to Expand U.S. Access to eyonis® LCS for AI-Powered Lung Cancer Screening
    GlobeNewswire 2mo ago
    Median Technologies and Olea sign partnership for lung cancer device

    Median Technologies and Olea sign partnership for lung cancer device
    Medical Device Network 3mo ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: